Crane NXT to improve counterfeit detection abilities via planned full acquisition of Italian inspection and detection firm Antares Vision
Summary
Crane NXT has signed definitive agreements to acquire a 30% stake in Antares Vision S.p.A. at €5.00 per share (≈€120 million), and will launch a mandatory tender offer in Italy for the remaining publicly traded shares at the same price. Antares Vision is a global provider of inspection and detection systems and track-and-trace software used to combat counterfeiting and to improve product visibility across supply chains.
The deal values Antares Vision’s enterprise (100% equity plus current net debt) at about €445 million. Crane NXT says the acquisition expands its technology portfolio into growth end markets such as Life Sciences and Food & Beverage; Antares reported around €200 million in revenue in FY24 with an adjusted EBITDA margin near 15%. Upon successful tender and closing, Crane NXT intends to take Antares private and delist it, making it a subsidiary.
Author style: Punchy — this is a strategic, sizeable deal that bolsters Crane NXT’s anti-counterfeit and inspection capabilities and positions it for regulatory-driven demand in pharma and food safety.
Key Points
- Crane NXT will buy a 30% stake for approximately €120 million and then make a mandatory tender offer for the remaining shares at €5.00 per share.
- Antares Vision specialises in inspection/detection systems and track-and-trace software aimed at preventing counterfeiting and improving supply-chain visibility.
- The transaction gives Antares an implied enterprise value of roughly €445 million for 100% of equity and net debt.
- Antares reported about €200 million revenue in FY24 with an adjusted EBITDA margin of ~15%.
- Crane NXT expects to delist Antares and fold it into the group, expanding into Life Sciences and Food & Beverage markets where regulatory pressure and anti-counterfeit demand are growing.
Why should I read this?
Short version: Crane NXT is making a major move to own a leading anti-counterfeit and inspection business. If you care about supply-chain integrity, payments technology tied to physical currency, pharmaceuticals, or food safety, this deal is worth a quick skim — it signals consolidation in inspection and track-and-trace tech and could shift competitive dynamics. We’ve read the detail so you don’t have to — this matters for compliance teams, manufacturers and investors tracking M&A in regulated sectors.
